Blog

Learn more about Pierian by browsing our resources below!

Our Latest Posts

Enabling Genomics in Practice

There are certain times in your life where a single sentence can

Employee Spotlight: Dr. Gerald Martin

Understanding the human genome has opened up incredible new

Employee Spotlight: Dr. Renee Sears, Clinical Genomics Specialist

Our Employee Spotlight shines a light on the uniqueness of the

Pierian Hackathon: 2021

“It’s funny what a good hackathon can do,” remarked Ankita Parikh,

Making Genomics the Standard of Care in Community Cancer Centers

According to recent estimates, almost 80% of cancer patients (1,2) in

Enabling High-Throughput Comprehensive Genomic Profiling

Comprehensive genomic profiling is emerging as a powerful tool in our

Enabling Targeted Sequencing with Minimal Complexity

Next generation sequencing continues to gain traction as a standard

Voices of Leaders Interview with Rakesh Nagarajan

What is the one thing we must do if we are to give complex disease a

Enabling Liquid Biopsy with Minimal Complexity

Precision medicine continues to gain traction, and increasingly,

Cancer in the Time of Coronavirus

Precision medicine is the ability to use genomic information to

The Personalized Diagnostics Podcast

Sequencing technology advances, such as comprehensive profiling

Visit Pierian at ACMG 2019

Pierian will be highlighting germline features of its genomics

Addressing Common Barriers to Clinical NGS Testing

Genomic tests that use next generation sequencing (NGS) technology

Why Are Other Healthcare Institutions Bringing Clinical NGS Testing In-House?

In just under 15 years, next generation sequencing (NGS) has evolved

The Hurdles of Making Clinical Sequencing a Reality

At PierianDx, we are well-versed in helping healthcare organizations

We Know Precision Medicine: Bryce Daines

Precision medicine is the ability to use genomic information to

Join us October 31- November 3 at the Association for Molecular

We Know Precision Medicine: Lisa Owen

Precision medicine is the ability to use genomic information to

Better Integrating Pathology into Cancer Care

In many healthcare settings the important role of pathology is

CAP Distributive Model of NGS Testing

Are you considering offering clinical NGS testing or looking for an

We Know Precision Medicine: Shalini Verma, Laboratory and Medical Director

We Know Precision Medicine is a series of blog posts and articles

A Guide for the Interpretation and Reporting of Sequence Variants in Cancer

Recently we hosted a webinar in which Medical Director, Shalini

We Know Precision Medicine: Andy Bredemeyer, VP Product

"We Know Precision Medicine" is a series of blog posts and articles

Less Variation, More Standardization in Somatic Variant Interpretation and Reporting

Preparing for our upcoming webinar -- A Practice-based Guide for

We Know Precision Medicine: Rakesh Nagarajan

"We Know Precision Medicine" is a series of blog posts and articles

PierianDx Expands to Australia with Addition of Anatomical Pathology PathWest Laboratory Medicine

PierianDx, the leading clinical genomics technology company that

PierianDx Hires Healthcare IT, Analytics Pioneer as CEO

MAY 24, 2018 -- ST. LOUIS -- PierianDx, the leader in clinical

PierianDx Partners with ScienceVision to Bring Robust Precision Medicine Support to Southeast Asia

MAY 14, 2018 -- ST. LOUIS -- PierianDx, the leading clinical genomics

University of Alabama takes a Dogged Approach to Precision Medicine

In the U.S. alone, there are nearly 700,000 people living with a

PierianDx Forms Strategic Partnership with Leading Research and Technical Services Organization RTI International

PierianDx, the leading genomics technology companythat

Optimizing the Bioinformatics Output of your Molecular Pathology Lab

One of America’s greatest inventors, Thomas Edison, didn’t invent the

PierianDx Showcases Germline Capabilities of its Clinical Genomics WorkSpace™ (CGW) Platform at ACMG 2018

PierianDx, the leading genomics technology company that

PierianDx Names Chris Callahan as Chief Commercial Officer to Drive Expansion of its Genomics Technology Platform for Clinical Labs

PierianDx named Chris Callahan as the new Chief Commercial Officer to

Cardiology Field Whole-heartedly Ready for Precision Medicine

Cardiovascular disease causes more deaths worldwide than any other

All of Us Initiative: Highlighting the Need for Streamlined Genetic Analysis

Flashback: the Human Genome Project was launched in 1990 by Nobel

Inova Launches Predictive Phenotyping Study with NIH

In case you missed it, PierianDx customer, Inova, is launching a

PierianDx to Unveil Blueprint for Bringing Next Generation Sequencing (NGS) Testing In-house at Executive War College

The drive to deliver precision medicine has galvanized many hospitals

Identifying Disease Risks Associated with Premature Mortality: A Study from Human Longevity

Life gets better when we enter our "golden years" and retire, doesn’t

PierianDx Customer, Moffitt Cancer Center, Launches Clinical NGS Assay, STAR

The Moffitt Morsani Molecular Laboratory, located within the Moffitt

PierianDx Showcases Germline Features in CGW at ACMG 2018

PierianDx will be highlighting germline features of its genomics

CMS NCD on Genomic Testing

CMS Final Coverage Decision for NGS: a Victory for Lab Developed Tests and Cancer Patients

When CMS initiated a national coverage analysis for NGS-based testing

Precision Medicine in Canada

We are excited to attend the upcoming Precision Oncology Experimental

PierianDx to Participate in 2nd International Precision Oncology and Experimental Therapeutics ‘POET’ Congress in Canada

On April 5 and 6 oncology leaders will convene in Calgary, Alberta to

Saving Infants with Genetic Testing

Genetic diseases are the leading cause of death for infants in North

PierianDx Customer Dartmouth-Hitchcock Medical Center Illustrates ALK-Rearranged Lung Cancer Patient Case in CAP Today Article

Laura J. Tafe, MD, associate professor of pathology and laboratory

Precision Medicine to Improve Patient Safety

While healthcare continues to improve, advances in technologies and

HIMSS18 Round-up: Why the Time for Precision Medicine is Now

by Brad Herrick, PierianDx Like most people who have been going to

PierianDx Launches Clinical Genomics Services to Accelerate Precision Medicine

PierianDx, the leading genomics technology company that

PierianDx Exhibiting at Health Systems Summit

PierianDx will be exhibiting at an intensive one-day summit for CEOs

PierianDx Hosts Expert Customer Panel Discussion Regarding Debated CMS National Coverage Decision on NGS Testing

PierianDx, the leading genomics technology company that

PharmaTech Outlook Spotlights PierianDx in December Issue

PharmaTech Outlook recently featured PierianDx in it’s December 2017

PierianDx Names New Additions to Sales and Clinical Genomic Solutions Teams

PierianDx announced today two key additions that will expand the

Moffitt Cancer Center Showcases its Blueprint for Building a Best-in-Class Precision Medicine Program at PierianDx-hosted Webinar

PierianDx, the forerunner in clinical genomic analysis,

PierianDx Announces Launch of Clinical Interpretation Services at ACMG 2017

New Service Combines Powerful Technology with Medical and Scientific

PierianDx Customers Cite 'Creative Partnership' on Clinical Genomics as Key Selling Point

NEW YORK (GenomeWeb) – Last week, PierianDx announced six new

PierianDx’s Partner Sharing Network Achieves Critical Mass with New Wave of Customers Adopting Clinical Genomics Workspace (CGW)

PierianDx announced today that six leading healthcare systems and

University of Vermont Touts the Importance of Clinical Integration to Accelerate Precision Medicine in PierianDx Webinar Series

PierianDx, the forerunner in clinical genomic analysis,

Doctors Use Computers More and Microscopes Less to Find Future Cancer Treatments

Not long ago, doctors hoping to cure human disease spent a lot of

PierianDx Named to CIOReview’s 20 Most Promising Cloud Solution Providers 2016

ST LOUIS – PierianDx, the forerunner in clinical genomic analysis,

PierianDx Announces Two New Board Members; Bryan Carey and Frederick Hessler Bring Vast Healthcare Experience

ST LOUIS, MO – PierianDx, the forerunner in clinical genomic

PierianDx Closes Series A Financing Led by Health Catalyst Capital Management; Company Poised for Next Stage of Growth

This financing will enable PierianDx to expand its lead as a pioneer

PierianDx Launches Exome Next Generation Sequencing Offering; Leading Medical Experts Shape Platform Functionality

ST LOUIS, MO – PierianDx, the forerunner in clinical genomic

PierianDx Builds Leadership Team to Accommodate Fast Growth Jim Howard Joins as Senior VP Sales

ST LOUIS, MO – PierianDx, the forerunner in clinical genomic

PierianDx Plans Software Update to Improve Variant Prioritization, Clinical Relevance Assessment

NEW YORK (GenomeWeb) – This summer, PierianDx plans to add a

PierianDx Introduces PDx Score to Quickly Prioritize Actionable Variants, While Expanding Industry-Leading Knowledgebase

ST LOUIS, MO – PierianDx announced today that its genomic testing

ARUP Introduces NGS.Web, a Powerful Next-Generation Sequencing Platform

ARUP Laboratories, a national nonprofit reference laboratory,

PierianDx Launches NGS Gateway Program

ST. LOUIS, MO – PierianDx, the forerunner in clinical genomic

PierianDx Founder and Chief Informatics Officer, Rakesh Nagarajan publishes article describing laboratory standards for Clinical Next-Generation Sequencing

PierianDx Founder and Chief Informatics Officer, Rakesh Nagarajan

PierianDx Launches the Clinical Genomicist Workstation for SaaS NGS Analysis

Washington University is throwing its hat in the clinical sequencing

PierianDx Licenses Diagnostic Genetic Sequencing Products from Washington University in St. Louis

ST. LOUIS, MO – PierianDx announced today that it has exclusively

Journal of Molecular Diagnostics

PierianDx Medical Advisor, Catherine Cottrell, Ph.D., FACMG,

Clinical NGS WUSTL

Rakesh Nagarajan, M.D., PhD., PierianDx Founder and Chief BioMedical